Sustained, long-term efficacy of pregabalin as treatment of neuropathic pain associated with diabetic peripheral neuropathy and post-herpetic neuralgia

被引:0
|
作者
Portenoy, R.
Sharma, U.
Young, J.
LaMoreaux, L.
Chartier, K.
机构
[1] Beth Israel Hosp, Dept Pain Med & Palliat care, New York, NY USA
[2] Pfizer Global Res & Dev, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:137 / 137
页数:1
相关论文
共 50 条
  • [1] Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
    Kostas Athanasakis
    Ioannis Petrakis
    Eleftheria Karampli
    Elli Vitsou
    Leonidas Lyras
    John Kyriopoulos
    [J]. BMC Neurology, 13
  • [2] Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
    Athanasakis, Kostas
    Petrakis, Ioannis
    Karampli, Eleftheria
    Vitsou, Elli
    Lyras, Leonidas
    Kyriopoulos, John
    [J]. BMC PSYCHIATRY, 2013, 13
  • [3] Pain therapy - Pregabalin for the treatment of post-herpetic neuralgia
    Diener, HC
    [J]. PSYCHOPHARMAKOTHERAPIE, 2005, 12 (01): : 35 - 36
  • [4] Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy
    Shoji, Satoshi
    Suzuki, Misaki
    Tomono, Yoshiro
    Bockbrader, Howard N.
    Matsui, Shigeyuki
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (01) : 63 - 76
  • [5] Pregabalin sustains its efficacy as long-term maintenance therapy for neuropathic pain associated with diabetic neuropathy and postherpetic neuralgia
    Portenoy, R
    Sharma, U
    Young, J
    Lamoreaux, L
    Chartier, K
    [J]. DIABETES, 2004, 53 : A142 - A142
  • [6] Pregabalin for the treatment of painful diabetic peripheral neuropathy and post-therapeutic neuralgia: Long-term efficacy characteristics
    Sharma, U.
    Portenoy, R.
    Young, J.
    LaMoreaux, L.
    Chartier, K.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 196 - 196
  • [7] Impact of pregabalin on cost of pharmacotherapy for diabetic peripheral neuropathy and post-herpetic neuralgia from a US perspective
    Sadosky, A.
    Vera-Llonch, M.
    Dukes, E.
    Oster, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 169 - 169
  • [8] Pregabalin in the treatment of neuropathic pain associated with diabetic peripheral neuropathy
    Frank, B.
    Cousins, M. J.
    [J]. FUTURE NEUROLOGY, 2008, 3 (06) : 631 - 639
  • [9] Reduction in neuropathic pain in patients with post-herpetic neuralgia, HIV-associated neuropathy or painful diabetic neuropathy following treatment with QUTENZA™ 8% capsaicin patch
    Webster, L. R.
    Backonja, M.
    Irving, G. A.
    Tobias, J. K.
    Vanhove, G. F.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 294 - 294
  • [10] Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia
    Rodriguez, M. J.
    Diaz, S.
    Vera-Lionch, M.
    Dukes, E.
    Rejas, J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) : 2585 - 2596